Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $31.3M | $35.3M | $45.9M | $33.2M | $11.7M | $13.9M |
| Revenue growth | — | 12.5% | 30.1% | -27.6% | -64.8% | 18.8% |
| Gross profit | — | — | — | $1.07B | $1.07B | $1.24B |
| Gross margin | — | — | — | 3222.6% | 9148.4% | 8890.6% |
| Operating income | $1.18M | -$5.36M | -$10.4M | -$7.70M | -$4.75M | -$9.79M |
| Operating margin | 3.8% | -15.2% | -22.7% | -23.2% | -40.6% | -70.5% |
| Net income | $2.35M | -$5.95M | -$9.61M | -$8.69M | -$5.97M | -$9.48M |
| Net margin | 7.5% | -16.9% | -20.9% | -26.2% | -51.0% | -68.2% |
| EPS (diluted) | $0.08 | -$0.20 | -$2.63 | -$2.08 | -$16,909.30 | -$152.30 |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$735K | -$7.11M | -$2.60M | -$2.15M | -$1.08M | -$16.5M |
| Capital expenditures | — | — | $40.0K | $12.0K | — | $6.00K |
| Free cash flow | — | — | -$2.64M | -$2.16M | — | -$16.5M |
| Share buybacks | — | — | $142K | — | — | — |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.40M | $1.77M | $1.34M | $1.23M | $20.0K | $7.63M |
| Total assets | $11.1M | $24.6M | $20.8M | $6.86M | $1.96M | $22.7M |
| Total liabilities | $6.78M | $8.48M | $8.38M | $8.25M | $7.08M | — |
| Shareholders' equity | $4.33M | $16.1M | $12.4M | -$1.39M | -$5.11M | $9.94M |
| Retained earnings | — | -$2.66M | -$12.6M | -$27.6M | -$33.6M | -$43.0M |
| Shares (wtd avg diluted) | 27.9M | 29.4M | 3.66M | 4.18M | 353M | 61.9B |
Every figure is extracted from Healthcare Triangle, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.